6WS1

Crystal structure of human phenylethanolamine N-methyltransferase (PNMT) in complex with (2S)-2-amino-4-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(7,8-dichloro-1,2,3,4-tetrahydroisoquinolin-4-yl)propyl)amino)butanoic acid and AdoHcy (SAH)

6WS1 の概要

• エントリーDOI: 10.2210/pdb6ws1/pdb
• 分子名称: Phenylethanolamine N-methyltransferase, S-ADENOSYL-L-HOMOCYSTEINE, 1,2-ETHANEDIOL, ... (7 entities in total)
• 機能のキーワード: transition state analogue, chemical synthesis, drug design, structural biology, neurodegenerative disease, pnmt, transferase
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 65986.80

構造登録者

Harijan, R.K.,Mahmoodi, N.,Bonanno, J.B.,Almo, S.C.,Schramm, V.L. (登録日: 2020-04-30, 公開日: 2020-08-05, 最終更新日: 2024-10-23)

主引用文献

Mahmoodi, N.,Harijan, R.K.,Schramm, V.L.
Transition-State Analogues of PhenylethanolamineN-Methyltransferase.
J.Am.Chem.Soc., 142:14222-14233, 2020

PubMed Abstract: Phenylethanolamine -methyltransferase (PNMT) is a critical enzyme in catecholamine synthesis. It transfers the methyl group of -adenosylmethionine (SAM) to catalyze the synthesis of epinephrine from norepinephrine. Epinephrine has been associated with diverse human processes, including the regulation of blood pressure and respiration, as well as neurodegeneration found in Alzheimer's disease. Human PNMT (hPNMT) proceeds through an S2 transition state (TS) in which the transfer of the methyl group is rate limiting. TS analogue enzyme inhibitors are specific for their target and bind orders of magnitude more tightly than their substrates. Molecules resembling the TS of hPNMT were designed, synthesized, and kinetically characterized. This new inhibitory scaffold was designed to mimic the geometry and electronic properties of the hPNMT TS. Synthetic efforts resulted in a tight-binding inhibitor with a value of 12.0 nM. This is among the first of the TS analogue inhibitors of methyltransferase enzymes to show an affinity in the nanomolar range. Isothermal titration calorimetry (ITC) measurements indicated negative cooperative binding of inhibitor to the dimeric protein, driven by favorable entropic contributions. Structural analysis revealed that inhibitor binds to hPNMT by filling the catalytic binding pockets for the cofactor (SAM) and the substrate (norepinephrine) binding sites.

PubMed: 32702980
DOI: 10.1021/jacs.0c05446

実験手法

X-RAY DIFFRACTION (2.76 Å)